<SEC-DOCUMENT>0001015820-25-000062-index.html : 20250902
<SEC-HEADER>0001015820-25-000062.hdr.sgml : 20250902
<ACCEPTANCE-DATETIME>20250829181204
ACCESSION NUMBER:		0001015820-25-000062
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20250831
FILED AS OF DATE:		20250902
DATE AS OF CHANGE:		20250829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QIAGEN N.V.
		CENTRAL INDEX KEY:			0001015820
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38332
		FILM NUMBER:		251282332

	BUSINESS ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912
		BUSINESS PHONE:		31-77-35566-00

	MAIL ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QIAGEN NV
		DATE OF NAME CHANGE:	19960531
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-kx2025convertibledebt.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: form6-kx2025convertibledebt.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99108282025pressrel.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: exhibit99108282025pressrel.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit99208282025pressrel.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 3 - file: exhibit99208282025pressrel.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_01.jpg
<TEXT>
Document 4 - file: image_01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_0a.jpg
<TEXT>
Document 5 - file: image_0a.jpg

</DOCUMENT>
</SEC-DOCUMENT>